The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial

EuroIntervention 2012;8:796-802. DOI: 10.4244/EIJV8I7A122

1. Fuwai Hospital, National Centre for Cardiovascular Diseases of China, Beijing, China; 2. Affiliated Anzhen Hospital of Capital Medical University, Beijing, China; 3. Affiliated Chaoyang Hospital of Capital Medical University, Beijing

Aims: This study sought to evaluate the safety and efficacy of the NOYA stent which is a cobalt chromium-based sirolimus-eluting stent (SES) wit

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique